Home
>
National Drug Code (NDC)
>
Claravis
Claravis - 0555-1055-56 - (isotretinoin)
Drug Information of Claravis
| Product NDC: | 0555-1055 |
| Proprietary Name: | Claravis |
| Non Proprietary Name: | isotretinoin |
| Active Ingredient(s): | 20 mg/1 & nbsp; isotretinoin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Claravis
| Product NDC: | 0555-1055 |
| Labeler Name: | Barr Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076135 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030509 |
Package Information of Claravis
| Package NDC: | 0555-1055-56 |
| Package Description: | 10 BLISTER PACK in 1 CARTON (0555-1055-56) > 10 CAPSULE in 1 BLISTER PACK |
NDC Information of Claravis
| NDC Code | 0555-1055-56 |
| Proprietary Name | Claravis |
| Package Description | 10 BLISTER PACK in 1 CARTON (0555-1055-56) > 10 CAPSULE in 1 BLISTER PACK |
| Product NDC | 0555-1055 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | isotretinoin |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20030509 |
| Marketing Category Name | ANDA |
| Labeler Name | Barr Laboratories, Inc. |
| Substance Name | ISOTRETINOIN |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Retinoid [EPC],Retinoids [Chemical/Ingredient] |
